Open Nav

Philip Toleikis

President, CEO

Sernova Corp.

Dr. Toleikis is currently President and Chief Executive Officer of Sernova Corp. From 2006 to 2009, Dr. Toleikis consulted for multiple device, combination product and pharmaceutical companies. From 1996 to 2006 he held multiple roles at Angiotech Pharmaceuticals, Inc. including Vice President, Research and Development - Pharmacology and Drug Screening where he built a product development team of over 50 scientists and was responsible for multiple corporate and academic product development collaborations.

While at Sernova, Dr. Toleikis has secured over $20 million in various forms of financings, including equity raises and multiple non-dilutive grants and has been responsible for negotiating a worldwide exclusive license with UHN for its stem cell derived technologies as well as developing business relationships and collaborations with multiple pharmaceutical and academic institutions involving its Cell Pouch™ device and cell technologies.

This speaker's sessions: